-- 欧州投資銀行は月曜日、地政学的圧力の高まりを受け、エネルギーのレジリエンス強化と先端技術革新を支援するため、24億ユーロ(28億2000万ドル)を超える新規融資を行うと発表した。 欧州投資基金(EIF)によると、この資金提供はハノーバーメッセで発表され、戦略的技術分野におけるグローバル競争と継続的なエネルギー課題に対する欧州の包括的な対応策の一環である。 EUブースで締結されたすべての協定はInvestEUプログラムによって裏付けられており、EU域内におけるイノベーション、技術移転、エネルギーレジリエンス強化への支援強化を反映している。 コメルツ銀行との提携の下、欧州投資銀行はドイツおよびその他のEU諸国における電力網への最大20億ユーロの投資を可能にするため、2億5000万ユーロの保証を提供する。 このイニシアチブは、ケーブルや変圧器などの主要電力網構成要素のサプライチェーンを強化するとともに、エネルギーネットワークのデジタル化と近代化を加速させることを目的としている。 欧州投資銀行(EIB)は、この仕組みによって民間資本が重要な送電網プロジェクトに投入され、エネルギー安全保障の向上、業界コストの削減、消費者向けシステムの信頼性強化に貢献することが期待されると述べた。 その他の投資には、ロボット工学、自動化、人工知能プロジェクトへの支援に加え、初期段階のディープテックファンド、大学発ベンチャー企業への資金提供、欧州全域におけるコンピューティング分野に特化したベンチャーキャピタル事業への投資が含まれる。 EIBのニコラ・ベア副総裁は、24億ユーロ規模のこの投資パッケージはエネルギー安全保障と基幹技術を支援するものであり、欧州の競争力と経済の回復力にとって不可欠であると述べた。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.